Clinical trials: Posterior Fossa Tumor, active
Posterior Fossa Ependymal Tumor
Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma
This is a multi-site study of the pharmacodynamic effects and efficacy of metformin in children and young adults with recurrent or progressive Posterior Fossa Group A (PFA) ependymoma.
- Trial name
- PNOC041 (NCT07226453)
- Testing
- Metformin, Planned Surgical Resection, Magnetic Resonance Imaging (MRI)
- Where
- 12 sites in United States
- Volunteers
- 30 people
- Sponsor
- University of California, San Francisco
Posterior Fossa Tumor
Dexmedetomidine Use for Greater Occipital Nerve Block in Pediatric Posterior Fossa Tumor Surgery.
The goal of this clinical trial is to evaluate the effects of ultrasound-guided versus blind greater occipital nerve block (GONB), with or without Dexmedetomidine as an adjuvant, in pediatric patients undergoing posterior fossa…
- Trial name
- NCT07878156
- Testing
- Bupivacaine 0.25%, Dexmedetomidine 1mcg/kg, Blind greater occipital nerve block
- Where
- Egypt
- Volunteers
- 260 people
- Sponsor
- Children's Cancer Hospital Egypt 57357
Posterior Fossa Brain Tumor Group, Healthy Control Group
Physical Performance and Quality of Life in Children With Brain Tumors
This study is designed to assess physical performance and quality of life in children with posterior fossa brain tumors compared to healthy children.
- Trial name
- NCT07810673
- Where
- Egypt
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Sarah Mohammed El-Abasiri
High-Grade Glioma (HGG), Posterior Fossa-A Ependymoma
A Safety and Efficacy Study of Combined Fianlimab + Cemiplimab in Children and Young Adults With Recurrent or Progressive High-Grade Glioma or Posterior Fossa-A Ependymoma
This study is researching an experimental drug called cemiplimab (called "study drug") and the combination of experimental drugs of fianlimab and cemiplimab (called "study drugs").
- Trial name
- NCT07567469
- Testing
- Cemiplimab, Cemiplimab+Fianlimab Fixed Dose Combination (FDC)
- Volunteers
- 120 people
- Sponsor
- Regeneron Pharmaceuticals
Pediatric Tumor, Midline Posterior Fossa Tumors
Pediatric Midline Post Fossa Tumors Prognostic Factors and Outcomes
This study will follow children younger than 18 years with midline posterior fossa brain tumors who undergo standard surgical resection at Assiut University Hospital.
- Trial name
- NCT07315230
- Volunteers
- 30 people
- Sponsor
- Assiut University
Posterior Fossa Lesion
Comparison of Surgical Outcomes of Craniotomy and Craniectomy in Posterior Fossa Lesions
The purpose of this randomized controlled trial is to compare the surgical outcomes of craniotomy and craniectomy among patients with posterior fossa lesions.
- Trial name
- NCT06831695
- Testing
- Craniotomy, Craniectomy
- Volunteers
- 80 people
- Sponsor
- University of Health Sciences Lahore
Posterior Fossa Tumor
Intensive Physiotherapy in Children Affected by Posterior Fossa Tumors
The objective of the current study is to describe the effectiveness of conventional and intensive physiotherapeutic intervention in improving gross motor skills (i.e.
- Trial name
- NCT06832384
- Testing
- intensive physiotherapy
- Where
- 3 sites in Italy
- Volunteers
- 40 people
- Sponsor
- IRCCS Eugenio Medea